Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Senseonics Holdings (NY: SENS )

0.3160 -0.0067 (-2.08%)
Official Closing Price Updated: 8:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Senseonics Holdings

< Previous 1 2 3 Next >
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
From Ascensia Diabetes Care
Via Business Wire
Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
From Senseonics Holdings, Inc.
Via Business Wire
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. to Participate in Upcoming Conferences
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Eversense® CGM System Receives iCGM Designation by the US FDA
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Announces Business Updates
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Reports Second Quarter 2023 Financial Results
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Holdings, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023 at 4:30 p.m. Eastern Time
From Senseonics Holdings, Inc.
Via Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
From Senseonics Holdings, Inc.
Via Business Wire
New Clinical Data Demonstrating the Safety and Accuracy of Eversense through 365 Days Presented at the American Diabetes Association 83rd Scientific Sessions
From Senseonics Holdings, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.